A Randomized, Phase 3, Open-Label Trial Comparing the Effect of LY3298176 Versus Titrated Insulin Degludec on Glycemic Control in Patients With Type 2 Diabetes
A Randomized, Phase 3, Open-Label Trial Comparing the Effect of LY3298176 Versus Titrated Insulin Degludec on Glycemic Control in Patients With Type 2 Diabetes
The purpose of this study is to compare the effect of the study drug tirzepatide to insulin degludec on blood sugar levels in participants with type 2 diabetes. The study will last about 67 weeks and may include up to 22 visits.
Inclusion Criteria:
Participants must:
Exclusion Criteria:
Participants must not:
CABA, Buenos Aires C1128AAF, Argentina
Caba, Buenos Aires C1179AAB, Argentina
Caba, Buenos Aires C1425DES, Argentina
Ciudad Autonoma de, Buenos Aires C1119ACN, Argentina
Ciudad Autonoma de Buenos Aire, C1120AAC, Argentina
Ciudad Autonoma de Buenos Aire, C1204AAD, Argentina
Ciudad Autonoma de Buenos Aire, C1440AAD, Argentina
N. Efkarpia, Thessaloniki 56403, Greece
Taichung County, 433, Taiwan